JP2021527125A5 - - Google Patents

Info

Publication number
JP2021527125A5
JP2021527125A5 JP2021518045A JP2021518045A JP2021527125A5 JP 2021527125 A5 JP2021527125 A5 JP 2021527125A5 JP 2021518045 A JP2021518045 A JP 2021518045A JP 2021518045 A JP2021518045 A JP 2021518045A JP 2021527125 A5 JP2021527125 A5 JP 2021527125A5
Authority
JP
Japan
Prior art keywords
compound according
teeth
halogen
och
double bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518045A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527125A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/035833 external-priority patent/WO2019236879A1/en
Publication of JP2021527125A publication Critical patent/JP2021527125A/ja
Publication of JP2021527125A5 publication Critical patent/JP2021527125A5/ja
Priority to JP2023203259A priority Critical patent/JP7576145B2/ja
Pending legal-status Critical Current

Links

JP2021518045A 2018-06-07 2019-06-06 Sarm1阻害剤 Pending JP2021527125A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023203259A JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862682033P 2018-06-07 2018-06-07
US62/682,033 2018-06-07
PCT/US2019/035833 WO2019236879A1 (en) 2018-06-07 2019-06-06 Inhibitors of sarm1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023203259A Division JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Publications (2)

Publication Number Publication Date
JP2021527125A JP2021527125A (ja) 2021-10-11
JP2021527125A5 true JP2021527125A5 (https=) 2022-06-22

Family

ID=68769462

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021518045A Pending JP2021527125A (ja) 2018-06-07 2019-06-06 Sarm1阻害剤
JP2023203259A Active JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023203259A Active JP7576145B2 (ja) 2018-06-07 2023-11-30 Sarm1阻害剤

Country Status (8)

Country Link
US (1) US12338238B2 (https=)
EP (1) EP3801500B1 (https=)
JP (2) JP2021527125A (https=)
CN (1) CN112839647B (https=)
CA (1) CA3102645A1 (https=)
ES (1) ES3028093T3 (https=)
MA (1) MA52813A (https=)
WO (1) WO2019236879A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112839647B (zh) 2018-06-07 2025-09-23 达萨玛治疗公司 Sarm1抑制剂
CN112839648B (zh) 2018-06-07 2025-04-04 达萨玛治疗公司 Sarm1抑制剂
EP3897670A4 (en) 2018-12-19 2022-09-07 Disarm Therapeutics, Inc. MRSA1 INHIBITORS IN COMBINATION WITH NEUROPROTECTIVE AGENTS
US12595252B2 (en) 2019-06-14 2026-04-07 Disarm Therapeutics, Inc. Inhibitors of SARM1
CA3150878A1 (en) 2019-09-12 2021-03-18 Jonathan Bentley Inhibitors of sarm1
JP7528212B2 (ja) * 2019-11-26 2024-08-05 ディスアーム セラピューティクス, インコーポレイテッド 神経保護のための方法および組成物
US12606558B2 (en) 2020-04-09 2026-04-21 Disarm Therapeutics, Inc. Condensed pyrazole derivatives as inhibitors of SARM1
US12435084B2 (en) 2020-04-09 2025-10-07 Eli Lilly And Company Indazole derivatives as inhibitors of SARM1
IL298577A (en) * 2020-05-27 2023-01-01 Emendobio Inc Biallelic silencing of sarm1
TWI904906B (zh) 2020-08-24 2025-11-11 美商達薩瑪治療公司 Sarm1之抑制劑
WO2023240084A2 (en) * 2022-06-06 2023-12-14 Denali Therapeutics Inc. Compounds, compositions, and methods
EP4539840A4 (en) * 2022-06-17 2026-04-15 Sundance Biosciences Inc Kinase Modulators and Their Methods of Use
WO2024158607A1 (en) 2023-01-24 2024-08-02 Disarm Therapeutics, Inc. Substituted 1h-pyrazole-4-carboxamides as sarm1 inhibitors
TW202509019A (zh) * 2023-04-27 2025-03-01 香港商維泰瑞隆(香港)生物科技有限公司 Sarm1調節子、其製劑及用途

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1022214A (en) 1963-01-31 1966-03-09 Sterling Drug Inc Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation
US3429887A (en) 1965-01-26 1969-02-25 Sterling Drug Inc 1,7-naphthyridine-3-carboxylic acid derivatives and their preparation
US3506668A (en) 1965-01-26 1970-04-14 Sterling Drug Inc Method of preparing 8-hydroxy-quinolines
US3429882A (en) 1968-03-25 1969-02-25 Geigy Chem Corp 1,2,8,9-tetraazaphenalenes
US3539567A (en) 1968-04-23 1970-11-10 Geigy Chem Corp 8-carboxy-1(2h) phthalazinones
US3761493A (en) 1968-04-23 1973-09-25 Ciba Geigy Corp 3-dibromomethylphthalic anhydride
US3624108A (en) 1968-04-23 1971-11-30 Geigy Chem Corp 7-carboxyphthalides
US3542777A (en) 1968-08-12 1970-11-24 Geigy Chem Corp Derivatives of 9-pyridylalkyl-1,2,8,9-tetraazaphenalenes
US3517014A (en) 1969-06-16 1970-06-23 Sterling Drug Inc Method of preparing 8-hydroxyquinoline-3-carboxylic acids
US3711473A (en) 1970-04-06 1973-01-16 Ciba Geigy Corp 3-hydrazino-1,2,8,9-tetraazaphenalenes
DE2449252A1 (de) 1973-10-16 1975-04-17 Fuji Photo Film Co Ltd Waermeentwickelbares, lichtempfindliches material
US4207112A (en) 1974-01-29 1980-06-10 Fuji Photo Film Co., Ltd. Heat developable light-sensitive materials
JPS50123331A (https=) 1974-03-14 1975-09-27
GB9310700D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Novel composition
WO2001081316A2 (en) 2000-04-27 2001-11-01 Abbott Laboratories Substituted phenyl farnesyltransferase inhibitors
US7109208B2 (en) * 2001-04-11 2006-09-19 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US20050222127A1 (en) * 2004-03-30 2005-10-06 Alcon, Inc. Use of Rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
US20060078890A1 (en) * 2004-10-08 2006-04-13 Ole Isacson Methods for identifying parkinson's disease therapeutics
CN101213187B (zh) * 2005-06-28 2012-06-06 塞诺菲-安万特股份有限公司 作为rho-激酶抑制剂的异喹啉衍生物
RS52241B (sr) * 2005-07-26 2012-10-31 Sanofi Derivati cikloheksilamin izohinolona kao inhibitori rho-kinaze
CN101277939A (zh) 2005-09-09 2008-10-01 布里斯托尔-迈尔斯斯奎布公司 无环ikur抑制剂
GB0605766D0 (en) 2006-03-22 2006-05-03 Ucb Sa Process
US20100004244A1 (en) * 2006-06-27 2010-01-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of cb2 receptor agonists for promoting neurogenesis
JP2009543801A (ja) * 2006-07-13 2009-12-10 ノバルティス アクチエンゲゼルシャフト 神経障害処置におけるトリフルオロメチル置換ベンズアミドの使用
CA2725014C (en) * 2008-05-30 2014-06-17 Amgen Inc. Inhibitors of pi3 kinase
JP2010053073A (ja) * 2008-08-28 2010-03-11 Sankyo Kasei Kk ハロゲン化イソキノリン類の製造方法
US8450363B2 (en) * 2009-02-06 2013-05-28 Elan Pharmaceuticals, Inc. Inhibitors of Jun N-terminal kinase
AU2012212323A1 (en) 2011-02-01 2013-09-12 The Board Of Trustees Of The University Of Illinois HDAC inhibitors and therapeutic methods using the same
DE102011009961A1 (de) * 2011-02-01 2012-08-02 Merck Patent Gmbh 7-Azaindolderivate
WO2012178022A2 (en) 2011-06-24 2012-12-27 University Of Massachusetts Therapeutic applications targeting sarm1
WO2013005157A1 (en) 2011-07-05 2013-01-10 Lupin Limited Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer
DE102012019369A1 (de) 2012-10-02 2014-04-03 Merck Patent Gmbh 7-Azaindolderivat
KR20160023854A (ko) 2013-06-24 2016-03-03 메르크 파텐트 게엠베하 프탈라진 유도체
WO2015050471A1 (en) * 2013-10-02 2015-04-09 Obschestvo S Ogranichennoy Otvetstvennost'yu "Panacela Labs" Carbazole compounds and methods of using same
WO2015102929A1 (en) * 2013-12-30 2015-07-09 Novartis Ag Tricyclic sulfonamide derivatives
FR3017868A1 (fr) 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2774923T3 (es) * 2014-04-28 2020-07-23 China Resources Pharmaceutical Holdings Company Ltd Derivados de isoquinolinsulfonilo como inhibidores de RHO quinasa
EP3188730B1 (en) * 2014-09-05 2019-05-01 Merck Sharp & Dohme Corp. Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
CA3011189C (en) 2016-01-14 2024-02-20 Bayer Pharma Aktiengesellschaft 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
WO2018035204A1 (en) 2016-08-16 2018-02-22 Henry Ford Health System Compositions for the treatment of neuropathic pain and sensitization of tumors to chemotherapies
JP7044789B2 (ja) 2016-09-24 2022-03-30 ワシントン・ユニバーシティ Sarm1 nadアーゼ活性の阻害剤およびその使用
US11098026B2 (en) * 2017-03-13 2021-08-24 Impetis Biosciences Limited Fused bicyclic compounds, compositions and applications thereof
CN112839648B (zh) 2018-06-07 2025-04-04 达萨玛治疗公司 Sarm1抑制剂
CN112839647B (zh) 2018-06-07 2025-09-23 达萨玛治疗公司 Sarm1抑制剂
CA3108669A1 (en) 2018-06-07 2019-12-12 Disarm Therapeutics, Inc. Inhibitors of sarm1
CN109223787A (zh) 2018-10-04 2019-01-18 南京先进生物材料与过程装备研究院有限公司 一种喜树碱和新型酞嗪酮类化合物联合用药物组合物
CN109336863A (zh) 2018-10-04 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种新型酞嗪酮类btk抑制剂、制备及其应用
CN109485636A (zh) 2018-10-04 2019-03-19 南京先进生物材料与过程装备研究院有限公司 一种新型btk激酶抑制剂的盐酸盐及其制备方法与用途
CN109180642A (zh) 2018-10-04 2019-01-11 南京先进生物材料与过程装备研究院有限公司 酞嗪酮类btk抑制剂及其应用
CN109293635A (zh) 2018-10-04 2019-02-01 南京先进生物材料与过程装备研究院有限公司 一种新型btk激酶抑制剂的p晶型及其制备方法
WO2020081923A1 (en) * 2018-10-19 2020-04-23 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with nad+ or a nad+ precursor
CN109276571A (zh) 2018-10-31 2019-01-29 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和新型硝基酞嗪酮btk抑制剂联合用药物组合物及其应用
CN109331018A (zh) 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和硝基酞嗪酮btk抑制剂联合用药物组合物及其应用
CN109481441A (zh) 2018-10-31 2019-03-19 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和新型甲氧基酞嗪酮类btk抑制剂联合用药物组合物及其应用
CN109172562A (zh) 2018-10-31 2019-01-11 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和甲氧基酞嗪酮类btk抑制剂联合用药物组合物及其应用
CN109394766A (zh) 2018-10-31 2019-03-01 南京先进生物材料与过程装备研究院有限公司 一种紫杉醇和对苯硝基酞嗪酮类btk抑制剂联合用药物组合物及其应用
EP4174170A4 (en) 2020-06-25 2023-12-06 FUJIFILM Corporation METHOD FOR PRODUCING INTESTINAL EPITHELIAL CELLS AND USE THEREOF

Similar Documents

Publication Publication Date Title
JP2021527125A5 (https=)
JP2024050527A5 (https=)
JP2021528488A5 (https=)
JP2008510691A5 (https=)
JP2019034943A5 (https=)
JP2024520481A5 (https=)
JP2021519783A5 (https=)
JP2021534124A5 (https=)
JP2021527638A5 (https=)
JP2020502103A5 (https=)
JP2017536395A5 (https=)
JP2022533069A5 (https=)
RU2003133448A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс- хемокинового рецептора
JP2015508068A5 (https=)
JP2016512505A5 (https=)
JP2023535815A5 (https=)
JP2022137237A5 (https=)
JP2022522694A5 (https=)
JP2023525571A5 (https=)
JP2002525329A5 (https=)
JP2022529806A5 (https=)
JP2010505865A5 (https=)
JP2024521895A5 (https=)
JPWO2023022216A5 (https=)
JP2023537271A5 (https=)